JAK3 (781-end), actif, GST étiqueté humain, PRECISIO Kinase, recombinant, exprimé en cellules bactériulovirus infectées Sf9 ,> = 70% (SDS - PAGE), solution de glycérol aqueuse tamponnée

Code: srp5041-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

JAK3 is a member of the JAK family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. Low levels of JAK3 expres...


en savoir plus

Votre prix
£461.00 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

JAK3 is a member of the JAK family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. Low levels of JAK3 expression is detected in immature hematopoietic cells, which dramatically increases during terminal differentiation of these cells suggesting a role of JAK3 in the differentiation of hematopoietic cells. Mutations in JAK3 are associated with autosomal SCID (severe combined immunodeficiency disease). Mice lacking JAK3 show a severe block in B-cell development at the pre-B stage in bone marrow suggesting that JAK3 is critical for the progression of B-cell development in the bone marrow.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... JAK3(3718)
mol wt~64 kDa
NCBI accession no.NM_000215
product linePRECISIO® Kinase
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity77-104 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: